Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531458

BOSTONBIO

img img img img
No Data Available

BOSTON BIO SYSTEMS LTD. Share Price Update

As of the latest trading session, BOSTON BIO SYSTEMS LTD. share price is currently at ₹ 8.2, which is up by ₹ 0.21 from its previous closing. Today, the stock has fluctuated between ₹ 7.75 and ₹ 8.37. Over the past year, BOSTON BIO SYSTEMS LTD. has achieved a return of -61.81 %. In the last month alone, the return has been 10.06 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BOSTON BIO SYSTEMS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    5.90

  • P/E Ratio (TTM)

    -12.09

  • Beta

    -0.45

  • Book Value / share

    8.54

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.04

info icon alternate text

BOSTON BIO SYSTEMS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 0.24
Operating Expense 0.24
Net Profit 0.04
Net Profit Margin (%) 16.66
Earnings Per Share (EPS) 0.06
EBITDA 0.10
Effective Tax Rate (%) 20.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.18
Operating Expense 0.16
Net Profit 0.04
Net Profit Margin (%) 22.22
Earnings Per Share (EPS) 0.06
EBITDA 0.08
Effective Tax Rate (%) 20.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.19
Operating Expense 0.68
Net Profit -0.49
Net Profit Margin (%) -257.89
Earnings Per Share (EPS) -0.70
EBITDA -0.49
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.05
Net Profit -0.05
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.07
EBITDA -0.05
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.19
Operating Expense 0.74
Net Profit -0.55
Net Profit Margin (%) -289.47
Earnings Per Share (EPS) -0.78
EBITDA -0.55
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit -0.14
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.20
EBITDA -0.14
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2018 (Values in Cr)
Revenue 0.66
Operating Expense 0.65
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2017 (Values in Cr)
Revenue 0.53
Operating Expense 0.53
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.05
EBITDA 0.00
Effective Tax Rate (%) 37.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.51
EBITDA Margin -289.47
Particulars MAR 2024 (Values in Cr)
Book Value / Share 9.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.41
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2018 (Values in Cr)
Book Value / Share 9.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 14.90
Total Liabilities 14.90
Total Equity 5.90
Share Outstanding 7002200
Price to Book Ratio 1.92
Return on Assets (%) -3.67
Return on Capital (%) -4.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 10.56
Total Liabilities 10.56
Total Equity 6.45
Share Outstanding 7002200
Price to Book Ratio 0.00
Return on Assets (%) -1.33
Return on Capital (%) -1.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 10.56
Total Liabilities 10.56
Total Equity 6.59
Share Outstanding 7002200
Price to Book Ratio 0.00
Return on Assets (%) -0.02
Return on Capital (%) -0.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 10.57
Total Liabilities 10.57
Total Equity 6.59
Share Outstanding 7002200
Price to Book Ratio 0.00
Return on Assets (%) -0.01
Return on Capital (%) -0.03
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 10.06
Total Liabilities 10.06
Total Equity 6.59
Share Outstanding 7002200
Price to Book Ratio 0.00
Return on Assets (%) 0.00
Return on Capital (%) 0
Particulars MAR 2025 (Values in Cr)
Net Income -0.54
Cash from Operations -4.58
Cash from Investing 0.00
Cash from Financing 4.57
Net change in Cash 0.00
Free Cash Flow -4.58
Particulars MAR 2024 (Values in Cr)
Net Income -0.14
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2018 (Values in Cr)
Net Income 0.00
Cash from Operations 0.12
Cash from Investing -0.07
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow 0.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7081.40 60.90 11.20 101819.67 6002.15 / 8099.00
FORTIS MALAR HOSPITALS LIMITED 59.12 24.43 3.22 110.80 55.15 / 98.70
SHREE PACETRONIX LTD. 155.80 24.69 3.49 57.25 61.11 / 283.15
TRANSGENE BIOTEK LTD. 2.95 0.00 2.42 22.35 2.59 / 5.26
VIMTA LABS LIMITED 619.15 45.46 8.06 2763.59 372.50 / 902.85
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7081.40 72.64 10.93 101819.67 6002.15 / 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
CHENNAI MEENAKSHI MULTISPECIAL 48.54 0.00 -14.10 36.26 28.34 / 57.48
KOVAI MEDICAL CENTER & HOSPITA 5708.10 27.32 5.24 6244.66 4810.20 / 6725.00

BOSTON BIO SYSTEMS LTD. shareholding pattern

Holding

97.85%
2.14%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BOSTON BIO SYSTEMS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
8.37 4.88 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 7.60
  • 26 Days 7.20
  • 10 Days 7.40
  • 50 Days 7.40
  • 12 Days 7.30
  • 100 Days 7.70
  • 20 Days 7.20
  • 200 Days 8.60
7.98 PIVOT

First Support

7.98

First Resistance

7.98

Second Support

7.98

Second Resistance

7.98

Third Support

7.98

Third Resistance

7.98

RSI

68.66

ADX

22.08

MACD

0.09

Williams % R

-1.82

Commodity Channel Index (CCI)

192.38

Date

2026-01-05

Week

1000.00

Same Day

284.00

Month

725.00

1 Year

-0.46

3 Year

-0.45

Over 1 Month

10.06%

down

Over 1 Year

-61.81%

down

Over 3 Months

-11.33%

down

Over 3 Years

0.00%

down

Over 6 Months

11.29%

down

Over 5 Years

0.00%

down

BOSTON BIO SYSTEMS LTD. Corporate Actions

BOSTON BIO SYSTEMS LTD. Share Price

Boston Bio Systems Limited was incorporated on April 17, 1995. Initially, Company was engaged in share broking. Presently, it trades in medical equipment, testing kits and instruments. The Company specialize in jobworking for herbal and health-related products, partnering with businesses to bring their formulations and ideas to life. With a strong foundation in natural wellness, Company is providing high-quality, custom solutions to the growing demand for herbal products and health supplements.

Apart from these, Company provide custom buffers to keep the projects running seamlessly. It customized manufacturing of herbal supplements, wellness products, and natural remedies. Private labeling for businesses are looking to market their own brand of herbal products. The Company also work for end-to-end product development, including formulation, packaging, and compliance.

Parent organization Indian Private
NSE symbol [-]
Founded 1995
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Boston Bio Systems Ltd?

Answer Field

Boston Bio Systems Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 8.37 as on Jan 06 2026 03:15 PM.

What is the Market Cap of Boston Bio Systems Ltd Share?

Answer Field

The market cap of Boston Bio Systems Ltd for NSE ₹ 0.00 & for BSE ₹ 5.90 as on Jan 06 2026 03:15 PM.

What is the 52 Week High and Low of Boston Bio Systems Ltd?

Answer Field

The 52 Week High and Low of Boston Bio Systems Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 22.00 and ₹ 6.36.

What is 1 year return for Boston Bio Systems Ltd?

Answer Field

The 1 year returns on the stock has been -61.81%.

What is the P/E Ratio of Boston Bio Systems Ltd Share?

Answer Field

As on Jan 06 2026 03:15 PM the price-to-earnings (PE) ratio for Boston Bio Systems Ltd share is -12.09.

What is the PB ratio of Boston Bio Systems Ltd Share?

Answer Field

As on Jan 06 2026 03:15 PM, the price-to-book (PB) ratio for Boston Bio Systems Ltd share is 8.54.

How to Buy Boston Bio Systems Ltd Share?

Answer Field

You can trade in Boston Bio Systems Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Boston Bio Systems Ltd Share on Bajaj Broking App?

Answer Field

To buy Boston Bio Systems Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Boston Bio Systems Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59